Molecular Docking Analysis of 9-Octadecene, 9,12,15-Octadecatrienoic acid, Methyl Ester, Phytol, 9,12-Octadecadienoic Acid and 9-Octadecenoic Acid with Anticancer Target Enzyme Caspase 3 (PDB: 1CP3)

Download Article

DOI: 10.21522/TIJPH.2013.12.04.Art097

Authors : P. Amudha, R. Vidya, V. Rani, M. Jayalakshmi, C. S. Kalpana

Abstract:

Computers and computing methods are commonly used in biological research today. In silico-molecular docking is a highly effective technology for identifying novel ligands for proteins with established structures and is crucial in the development of structure-based medicines. Caspase 3 plays a central role in apoptosis and splits many protein substrates in the cell when activated, which leads to cell death. Since it is known that many chemotherapies drugs trigger apoptosis in cancer cells, the promotion or activation of apoptosis through targeted control of apoptosis regulators has been proposed as a promising strategy for the discovery of cancer drugs. Therefore, in this present study in silico-molecular docking was carried out to determine the binding properties of 9-octadecene, 9, 12 and methyl ester, phytol, 15-octadecatrienoic acid, 9 and 12-octadecadien acids and 9-octadecenoic acid and target Protein 1CP3 (Caspase3). The study suggests that methyl ester, 9-octadecene, 9, 12-octadecadinenoic acid, phytol, 9,12,15-octadecatrienoic acid and phytol can inhibit caspase-3. Among the various phyto-compounds, 9,12,15-octadecatrienoic acid has more possible bond interactions than other compounds. Therefore, this study can serve as evidence of in vivo cancer activity that helps these molecules to come onto the market as over-the-counter medicines.

References:

[1].  Krovat, E.M., Steindl, T., Langer, T., 2005, Recent advances in docking and scoring. Current computer-aided drug design. 1(1):93-102. https://doi.org/10.2174/1573409052952314

[2].  Venkatesan, S.K., Shukla, A.K., Dubey, V.K., 2010, Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum. Journal of Computational Chemistry. 31(13):2463-75. https://doi.org/10.1002/jcc.21538

[3].  Tirumala, M.G., Anchi, P., Raja, S., Rachamalla, M., Godugu, C., 2021, Novel methods and approaches for safety evaluation of nanoparticle formulations: A focus towards in vitro models and adverse outcome pathways. Frontiers in pharmacology. 12:612659. https://doi.org/10.3389/fphar.2021.612659

[4].  Porter, A.G., Jänicke, R.U., 1999, Emerging roles of caspase-3 in apoptosis. Cell death & differentiation, 6(2), 99-104. https://doi.org/10.1038/sj.cdd.4400476

[5].  McIlwain, D.R., Berger, T., Mak, T.W., 2013, Caspase functions in cell death and disease. Cold Spring Harbor perspectives in biology. 5(4):a008656. DOI: 10.1101/cshperspect.a008656

[6].  Tuffery, P., Derreumaux, P., 2012, Flexibility and binding affinity in protein–ligand, protein–protein and multi-component protein interactions: limitations of current computational approaches. Journal of The Royal Society Interface. 9(66):20-33. https://doi.org/10.1098/rsif.2011.0584

[7].  Ghose, A.K., Crippen, G.M., 1987, Atomic physicochemical parameters for three dimensional-structure-directed quantitative structure activity relationships. Modelling dispersive and hydrophobic interactions. Journal of chemical information and computer sciences. 27, 21–35. https://doi.org/10.1021/ci00053a005

[8].  Binkowski, T.A., Naghibzadeg, S., Liang, J., 2003, CASTp computed atlas of surface topography of proteins. Nucleic acids research. 31, 3352– 3355. https://doi.org/10.1093/nar/gkg512

[9].  Vidya, S.M., Krishna, V., Manjunatha, B.K., Rajesh, K.P., Bharath, B.R., Manjunatha, H., 2012, Antibacterial and molecular docking studies of entagenic acid, a bioactive principle from seed kernel of Entada pursaetha. DC. Medicinal Chemistry Research. 21, 3195-3203. https://doi.org/10.1007/s00044-011-9614-4

[10]. Trott, O., Olson, A.J., 2010, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry. 31, 455–461. https://doi.org/10.1002/jcc.21334

[11]. Van De Waterbeemd, H., Gifford, E., 2003, ADMET in silico modelling: towards prediction paradise? Nature reviews Drug discovery. 192–204. https://doi.org/10.1038/nrd1032

[12]. Stennicke, H.R., Ryan, C.A., Salvesen, G.S., 2002, Reprieval from execution: the molecular basis of caspase inhibition. Trends in biochemical sciences. 27(2), 94-101. https://doi.org/10.1016/S0968-0004(01)02045-X

[13]. Stennicke, H.R., Salvesen, G.S., 1999, Catalytic properties of the caspases. Cell Death & Differentiation. 6(11), 1054-9. https://doi.org/10.1038/sj.cdd.4400599

[14]. Web, S.J., Harrison, D.J., Willey, A.H., 1997, In Apoptosis: Pharmacological Implication sand Therapeutic Opportunities, S.H. Kaufmann (Ed.), San Diego, Academic Press.

[15]. Nuttall, M.E., Lee, D., McLaughlin, B., Erhardt, J.A., 2001, Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies. Drug Discovery Today, 6(2), 85-91. https://doi.org/10.1016/S1359-6446(00)01601-9

[16]. Persad, R., Liu, C., Wu, T.T., Houlihan, P.S., Hamilton, S.R., Diehl, A.M., Rashid, A., 2004, Overexpression of caspase-3 in hepatocellular carcinomas. Modern pathology. 17(7):861-7. https://doi.org/10.1038/modpathol.3800146

[17]. Chang, Y.J., Linh, N.H., Shih, Y.H., Yu, H.M., Li, M.S., Chen, Y.R., 2016, Alzheimer's amyloid-beta sequesters caspase-3 in vitro via its C-terminal tail. ACS Chemical Neuroscience. 7, 1097-1106. https://doi.org/10.1021/acschemneuro.6b00049

[18]. Flanagan. L., Meyer, M., Fay, J., Curry, S., Bacon, O., Duessmann, H., John, K., Boland, K.C., McNamara, D.A., Kay, E.W., Bantel, H., Schulze-Bergkamen, H., Prehn, J.H., 2016, Low levels of caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: caspase-3 inhibition as a therapeutic approach. Cell death & disease. 7, e2087. https://doi.org/10.1038/cddis.2016.7

[19]. Yadav, P., Yadav, R., Jain, S., Vaidya, A., 2021, Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy. Chemical biology & drug design. 98(1):144-65. https://doi.org/10.1111/cbdd.13860

[20]. Srivastava, S., Singh, P., Jha, K.K., Mishra, G., Srivastava, S., Khosa, RL., 2012, Evaluation of anti-arthritic potential of the methanolic extract of the aerial parts of Costus speciosus. Journal of Ayurveda and integrative medicine. 3(4), 204-8. DOI: 10.4103/0975-9476.104443.

[21]. Tabassum, S., Zaki, M., Afzal, M., Arjmand, F., 2014, Synthesis and characterization of Cu (II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines. European journal of medicinal chemistry. 74, 509–523. https://doi.org/10.1016/j.ejmech.2013.12.046

[22]. Zhang, Y., Lee, P., Liang, S., Zhou, Z., Wu, X., Yang, F., Liang, H., 2015, Structural basis of non‐steroidal anti‐inflammatory drug diclofenac binding to human serum albumin. Chemical biology & drug design, 86(5), 1178-1184. https://doi.org/10.1111/cbdd.12583